Nextgen - Asset Resilience Ratio
Nextgen (NXGN) has an Asset Resilience Ratio of 0.12% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2020)
This chart shows how Nextgen's Asset Resilience Ratio has changed over time. Check Nextgen (NXGN) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Nextgen's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Nextgen market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA15.00K | 0.12% |
| Total Liquid Assets | ILA15.00K | 0.12% |
Asset Resilience Insights
- Limited Liquidity: Nextgen maintains only 0.12% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nextgen Industry Peers by Asset Resilience Ratio
Compare Nextgen's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Poly Medicure Limited
NSE:POLYMED |
Medical Instruments & Supplies | 18.86% |
|
Shanghai Tofflon Science Tech
SHE:300171 |
Medical Instruments & Supplies | 5.96% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Zhejiang Gongdong Medical Technology Co Ltd
SHG:605369 |
Medical Instruments & Supplies | 4.24% |
|
Touchstone International Medical Science Co Ltd
SHG:688013 |
Medical Instruments & Supplies | 37.86% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for Nextgen (2019–2020)
The table below shows the annual Asset Resilience Ratio data for Nextgen.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.23% | ILA19.00K ≈ $50.94 |
ILA8.32 Million ≈ $22.31K |
-0.75pp |
| 2019-12-31 | 0.98% | ILA19.00K ≈ $50.94 |
ILA1.93 Million ≈ $5.18K |
-- |
About Nextgen
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.